Know2eat

Mucuna pruriens

Mucuna pruriens

Herbs & Botanicals

What mucuna pruriens may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedCognitive functionLimited evidence· 4 sources

Then, in order

About Mucuna pruriens

A tropical legume seed containing levodopa, the same molecule used as prescription therapy for Parkinson’s disease, at roughly 3–6% of seed weight in unprocessed material.

Mucuna is not really a herbal supplement in behaviour; it is an uncontrolled dose of a potent prescription drug. Small crossover studies in Parkinson’s disease found mucuna seed powder produced a faster onset and comparable motor response to standard levodopa-carbidopa. The absence of a decarboxylase inhibitor means more peripheral levodopa and more nausea, and the levodopa content of retail products varies enough that a consistent dose is not achievable.

Sold as
Seed powder, Standardised extract capsule, Whole beans (require processing)
Standardised to
Commonly standardised to 15–98% L-dopa; whole seed powder is around 3–6% — a product without this marker may not resemble what was studied.
Also known as
Velvet bean, Kapikacchu, Cowhage, Kaunch beej

Regulation: Levodopa is a prescription medicine in most countries; the same molecule sold as a botanical extract sits outside that framework with no dose control and no clinical supervision.

What the research used

The amounts, forms and durations published trials of Mucuna pruriens actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Parkinson’s disease motor symptoms, in research settings

    15–30 g

    Limited

    Seed powder, providing roughly 500–1000 mg levodopa per dose · Single dose to 8 weeks

    These were small crossover studies conducted under specialist supervision with levodopa content assayed. Retail products state L-dopa percentages that independent testing has often failed to confirm, so equivalent dosing at home is not realistic.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

Each timing below was actually compared against an alternative in a trial, which is unusual.

  • On an empty stomach

    Moderate

    Levodopa absorption is reduced by dietary protein competing for the same transporter, which is established pharmacology for the prescription drug and applies to this source of it.

    Timing was tested. A trial compared this window against another and reported a difference.

The evidence in depth

Best supported: Limited

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Small crossover studies in Parkinson’s disease report improvements in motor function comparable to standard levodopa preparations, with faster onset. These were specialist studies with assayed material, and Parkinson’s disease requires neurological care rather than self-medication.

What may be going on: The seed contains levodopa, which crosses the blood-brain barrier and is converted to dopamine.

Limited evidence. Early human work, or mostly lab and animal research.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Evidence is limited for mucuna and mood or motivation in people without Parkinson’s disease. Marketing claims about dopamine and wellbeing are not supported by trials in healthy adults.

Not enough evidence. Not enough human research to say anything useful yet.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Interaction

    It is levodopa, with levodopa’s interactions

    Interacts withLevodopa-carbidopa, MAO inhibitors, antipsychotics, metoclopramide

    Combining mucuna with prescribed levodopa risks overdose and dyskinesia; combining it with MAO inhibitors risks hypertensive crisis; and it opposes antipsychotics and metoclopramide. Anyone on Parkinson’s medication should not add it without their neurologist.

  • Worth knowing

    Nausea, hypotension and psychiatric effects

    Without a peripheral decarboxylase inhibitor, more levodopa is converted outside the brain, producing nausea, vomiting and low blood pressure. Confusion, hallucinations and impulse-control problems are recognised effects of levodopa exposure.

  • Worth knowing

    Unreliable levodopa content

    Independent testing has found retail mucuna products with levodopa far from label claim in both directions. With a drug of this potency, that is a dosing problem, not a quality inconvenience.

  • Avoid

    Pregnancy, breastfeeding, melanoma and psychiatric illness

    Levodopa is avoided in pregnancy and breastfeeding, in people with melanoma, and in psychotic illness where dopaminergic drugs can worsen symptoms.

  • Allergy

    The pod hairs cause intense itching

    Unprocessed mucuna pods are covered in spicules containing mucunain, historically used as itching powder. Raw plant material requires processing.

Evidence ratings on this page: 1 limited evidence, 1 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Mucuna pruriens, or a dose to follow.